by Doctors, economists, lawmakers, and civil society groups fighting the WTO waiver are funded by the pharmaceutical lobby.JUST BEFORE GOING live on Al Jazeera last week, Achal Prabhala, an activist for equitable access to medicine, performed a quick internet search on his sparring partner in a debate on the proposal to share vaccine technology with low-income countries.It didn’t take long before Prabhala found that his opponent, an academic who favors pharmaceutical monopoly rights, leads an institute at Duke University funded by Pfizer and AstraZeneca. He pointed this fact out to the producers on air.The apparent conflict of interest is hardly a rare occurrence.The InterceptLee Fang - DRUG INDUSTRY MONEY QUIETLY BACKS MEDIA VOICES AGAINST SHARING VACCINE PATENTS
Topics:
Mike Norman considers the following as important:
This could be interesting, too:
New Economics Foundation writes Is the Labour government delivering on its promises?
Robert Vienneau writes Why Is Marginalist Economics Wrong?
John Quiggin writes Dispensing with the US-centric financial system
New Economics Foundation writes Whose growth is it anyway?
Doctors, economists, lawmakers, and civil society groups fighting the WTO waiver are funded by the pharmaceutical lobby.
JUST BEFORE GOING live on Al Jazeera last week, Achal Prabhala, an activist for equitable access to medicine, performed a quick internet search on his sparring partner in a debate on the proposal to share vaccine technology with low-income countries.
It didn’t take long before Prabhala found that his opponent, an academic who favors pharmaceutical monopoly rights, leads an institute at Duke University funded by Pfizer and AstraZeneca. He pointed this fact out to the producers on air.
The apparent conflict of interest is hardly a rare occurrence.
The Intercept
Lee Fang - DRUG INDUSTRY MONEY QUIETLY BACKS MEDIA VOICES AGAINST SHARING VACCINE PATENTS